Fibromyalgia Trial, Recruiting (NCT06948500)

Fibromyalgia Trial, Recruiting NCT06948500 Sponsor: Cardenal Herrera University Condition: Fibromyalgia

Printed from Voxsanity (voxsanity.com.au) — NCT06948500 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Fibromyalgia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults who have been diagnosed with fibromyalgia using any of the standard diagnostic guidelines set by the American College of Rheumatology (from 1990, 2010, 2011, or 2016)
People who are able to communicate clearly with the research team
People who rate their pain as 3 or higher on an 11-point scale, where 0 means no pain and 10 means the worst pain imaginable

Who may not be able to join:

People who have other health conditions or symptoms that would make it unsafe for them to use immersive virtual reality technology or take part in exercise-based activities (confirm with trial site)
People with health conditions that could affect the study's results, such as problems with vision, hearing, or sensory perception
People who are taking medications that could potentially influence the study's results (confirm with trial site)
People who are already taking part in another structured physical activity or therapy program during the study period, or who plan to make changes to their current treatments — including medications or physical therapy — while the study is ongoing

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Juan F Lisón, PhD, Cardenal Herrera University

Phone: 606503108

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06948500

Sponsor: Cardenal Herrera University

Phase: Not Applicable

Status: Recruiting

Condition: Fibromyalgia

Trial contact: 606503108

More information: https://clinicaltrials.gov/study/NCT06948500

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults who have been diagnosed with fibromyalgia using any of the standard diagnostic guidelines set by the American College of Rheumatology (from 1990, 2010, 2011, or 2016)
People who are able to communicate clearly with the research team
People who rate their pain as 3 or higher on an 11-point scale, where 0 means no pain and 10 means the worst pain imaginable

Who may not be able to join:

People who have other health conditions or symptoms that would make it unsafe for them to use immersive virtual reality technology or take part in exercise-based activities (confirm with trial site)
People with health conditions that could affect the study's results, such as problems with vision, hearing, or sensory perception
People who are taking medications that could potentially influence the study's results (confirm with trial site)
People who are already taking part in another structured physical activity or therapy program during the study period, or who plan to make changes to their current treatments — including medications or physical therapy — while the study is ongoing

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cardenal Herrera University

Registry

ClinicalTrials.gov

Start date

5 May 2025

Est. completion

1 December 2026

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Fibromyalgia Impact

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov